Background The emerging SARS-CoV-2 variant of concern (VOC) B. 1.6. 17.2 (Delta)
quickly displaced the B. 1.1. 7 (Alpha) and is associated with increases in COVID-19 cases …

Background The increase in SARS-CoV-2 infections in December 2021 was driven
primarily by the Omicron variant, which largely displaced the Delta over a three-week span. …

Background The increase in SARS-CoV-2 infections in December 2021 in the United States
was driven primarily by the Omicron variant which largely displaced the Delta over a three …

Background The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) variant of
concern (VOC) B.1.617.2 (Delta) displaced B.1.1.7 (Alpha) and is associated with increases …

Understanding the mechanisms of antibody-mediated neutralization of SARS-CoV-2 is critical
in combating the COVID-19 pandemic. Based on previous reports of antibody catalysis, …

Long-lived HIV-1 reservoirs that persist despite antiretroviral therapy (ART) are a major
impediment to a cure for HIV-1. We examined whether human liver macrophages (LMs), the …

Benchmarks for protective immunity from infection or severe disease after SARS-CoV-2
vaccination are still being defined. Here, we characterized virus neutralizing and ELISA antibody …

Ensuring SARS-CoV-2 diagnostics that can reliably detect emerging variants has been an
ongoing challenge. Due to the rapid spread of the Omicron variant, point-of-care (POC) …

Background The variant of concern Omicron has become the sole circulating severe acute
respiratory syndrome coronavirus 2 (SARS-CoV-2) variant for the past several months. …

Objective: To evaluate the association of COVID-19 outcomes following confirmed infection
with vaccination status, mucosal antibody responses, infectious virus recovery and viral RNA …